Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management

Since their invention in the early 2000s, tyrosine kinase inhibitors (TKIs) have gained prominence as the most effective pathway-directed anti-cancer agents. TKIs have shown significant utility in the treatment of multiple hematological malignancies and solid tumors, including chronic myelogenous le...

Descripción completa

Detalles Bibliográficos
Autores principales: Shyam Sunder, Sunitha, Sharma, Umesh C., Pokharel, Saraswati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326056/
https://www.ncbi.nlm.nih.gov/pubmed/37414756
http://dx.doi.org/10.1038/s41392-023-01469-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326056/
https://www.ncbi.nlm.nih.gov/pubmed/37414756
http://dx.doi.org/10.1038/s41392-023-01469-6

Ejemplares similares